Become A Featured Company

Will Albania’s EU Membership Be Scuttled by Domestic Cannabis Production?

Marguerite Arnold

October 15th, 2018

Policy

Cannabis has now entered the highest levels of the European Union’s political debate. So much so that production (albeit of the illicit kind) in one country, Albania, is now being used by some members of the EU in Brussels to refuse the country’s bid to join the economic union. Most notably the loudest objections are coming from France, which has yet to move on cannabis reform in general.

According to the Financial Times in 2017, at least, Albania produces the largest amount of illegal cannabis in any country on the continent. This in turn, serves as financing for organized crime that, according to authorities, seeps into Europe.

Production In The Ring States

Is this hypocritical? Does it smell suspiciously like a debate about both medical use and broader recreational reform on a European level that is frequently going off the rails these days for no reason?

Yes, to both questions. Especially given the current state of cannabis production gearing up all over the Mediterranean, from Spain in the west, to Greece and Malta further east. Not to mention what is going on in Macedonia and other border EU countries.

Cheaper labour markets ringing the EU are beginning to wake up to the entire cannabis economy question.

And that is the real issue, beyond the Albanian debate itself.

The EU, at the Brussels level is not copacetic about regional cannabis reform and is well aware of what is going on in an emerging market. This is showing up in various faces all over the continent, from the Spanish police removing CBD products from shelves to the drama at the Deutsche Börse about clearing public cannabis stocks.

And in the meantime, member states, particularly those who have not moved on national reform at all, are using cannabis as a convenient political lever. See Albania.

What this situation really demonstrates is how political the cannabis debate really is right now in Europe. And how indicative of the ducking and dodging if not the size and number of political hoops those in the market at this point, have had to jump through so far.

And how threatened, finally, the current status quo on cannabis reform really is.

The Impact On EU Reform

Regardless of both the immediate and long term impact on the Albanian situation, the forces of reform are afoot now at a regional not just a country level, in Europe. Expect the situation for the next several years to be fluid at a regional level while different sovereign countries adjust to a world of both still relatively open borders and legalizing cannabis.

This is exacerbated right now as the larger, legal Canadian LPs in particular, begin cultivation operations all over the continent and are setting up sophisticated distribution networks which span multiple countries (albeit with Germany still mostly as their largest destination point.)

It is also not going unnoticed that relatively poorer states with lower labour costs, i.e. on the fringes of EU economic activity, are eyeing the cannabis bandwagon with something akin to economic salvation. See the situation in Greece.

Add the additional political tensions of Brexit (where a still supposedly departing UK has now rescheduled the drug to a Schedule II, starting this month), and the topic of the great green plant is clearly causing headaches in Brussels that are not going to abate until cannabis legalization, finally, of some kind, is implemented at a regional economic bloc level.

In the meantime, the poorer countries of the region, hoping to play the cannabis card, as well as the companies now looking to exploit such opportunities, are going to have to engage in a continual political and lobbying game to make sure their newly found rights do not go up in smoke along with newly hatched cultivation and export dreams.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Marguerite Arnold

Marguerite Arnold is a veteran investigative and markets journalist, American expat and author. She has covered the cannabis industry from Germany for the last six years. Her book, Green: The First Year of Modern American Cannabis Reform about the American market in 2014 has just been republished as she is writing the sequel about Europe and the global revolution this year. Green II: Spreading Like Kudzu will be published in 2020. She is also a noted technologist and entrepreneur. Her blockchain-based digital prescription platform MedPayRx was just shortlisted by the German Ministry of Health as one of the "Top 20" use cases for blockchain in healthcare.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading